{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T13:04:18Z","timestamp":1695647058017},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1097\/fpc.0000000000000257","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T19:12:43Z","timestamp":1480792363000},"page":"51-56","source":"Crossref","is-referenced-by-count":5,"title":["A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis"],"prefix":"10.1097","volume":"27","author":[{"given":"Lara","family":"Colleoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Galbardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Barzago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Franzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Frangiamore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Camera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Foti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Biancolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Canioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimos","family":"Kapetis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210213","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J Clin Invest"},{"key":"R2-2-20210213","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ncpneuro0810","article-title":"Steroids and immunosuppressant drugs in myasthenia gravis","volume":"4","author":"Sathasivam","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"R3-2-20210213","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00314245","article-title":"Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis","volume":"235","author":"Mantegazza","year":"1988","journal-title":"J Neurol"},{"key":"R4-2-20210213","first-page":"75","article-title":"Azathioprine for multiple sclerosis","volume":"4","author":"Casetta","year":"2012","journal-title":"Eur Neurol J"},{"key":"R5-2-20210213","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/138955708785132756","article-title":"Azathioprine in multiple sclerosis","volume":"8","author":"Invernizzi","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"R6-2-20210213","first-page":"CD001461","article-title":"Azathioprine for treating rheumatoid arthritis","volume":"4","author":"Suarez-Almazor","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-2-20210213","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0168-8278(01)00196-9","article-title":"Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury","volume":"35","author":"Lee","year":"2001","journal-title":"J Hepatol"},{"key":"R8-2-20210213","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/sj.onc.1209372","article-title":"Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions","volume":"11","author":"Wang","year":"2006","journal-title":"Oncogene"},{"key":"R9-2-20210213","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/FPC.0b013e32835f1cc0","article-title":"Nomenclature for alleles of the thiopurine methyltransferase gene","volume":"23","author":"Appell","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"R10-2-20210213","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity","volume":"32","author":"Weinshilboum","year":"1980","journal-title":"Am J Hum Genet"},{"key":"R11-2-20210213","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2146\/ajhp120179","article-title":"Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus","volume":"69","author":"Nagamine","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"R12-2-20210213","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00535-010-0248-y","article-title":"The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease","volume":"45","author":"Ban","year":"2010","journal-title":"J Gastroenterol"},{"key":"R13-2-20210213","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ng.3060","article-title":"A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia","volume":"9","author":"Yang","year":"2014","journal-title":"Nat Genet"},{"key":"R14-2-20210213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ibd.20004","article-title":"Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease","volume":"13","author":"Stocco","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R15-2-20210213","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.23330","article-title":"Recommendations for myasthenia gravis clinical trials","volume":"45","author":"Benatar","year":"2012","journal-title":"Muscle Nerve"},{"key":"R16-2-20210213","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/0003-4819-145-10-200611210-00007","article-title":"Pharmacogenomics: challenges and opportunities","volume":"145","author":"Roden","year":"2006","journal-title":"Ann Intern Med"},{"key":"R17-2-20210213","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2217\/pgs.09.154","article-title":"Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform","volume":"11","author":"Sissung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"R18-2-20210213","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2217\/14622416.8.3.293","article-title":"Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System","volume":"8","author":"Dumaual","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R19-2-20210213","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-60761-663-4_7","article-title":"DMET microarray technology for pharmacogenomics-based personalized medicine","volume":"632","author":"Burmester","year":"2010","journal-title":"Methods Mol Biol"},{"key":"R20-2-20210213","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"R21-2-20210213","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1365-2036.2008.03788.x","article-title":"Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease","volume":"28","author":"Ansari","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/521987","article-title":"Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering","volume":"81","author":"Browning","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/bioinformatics\/btm025","article-title":"SNPassoc: an R package to perform whole genome association studies","volume":"23","author":"Gonz\u00e1lez","year":"2007","journal-title":"Bioinformatics"},{"key":"R25-2-20210213","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"R26-2-20210213","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/338688","article-title":"Score tests for association between traits and haplotypes when linkage phase is ambiguous","volume":"70","author":"Schaid","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R27-2-20210213","first-page":"1","article-title":"Pharmacogenomics-Guided approaches to avoiding adverse drug reactions","volume":"1","author":"Chen","year":"2012","journal-title":"Clin Pharmacol Biopharm"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1093\/hmg\/dds341","article-title":"Pharmacogenomics of adverse drug reactions: Implementing personalized medicine","volume":"21","author":"Wei","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R29-2-20210213","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1001\/jamainternmed.2014.5266","article-title":"Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels","volume":"174","author":"Wang","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R31-2-20210213","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/tpj.2009.57","article-title":"A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform","volume":"10","author":"Deeken","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"R32-2-20210213","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-07-6790","article-title":"Transporter-mediated protection against thiopurine-induced hematopoietic toxicity","volume":"68","author":"Krishnamurthy","year":"2008","journal-title":"Cancer Res"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.GR-1649R","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.clpt.6100019","article-title":"Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein","volume":"81","author":"De Jong","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R35-2-20210213","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/mutage\/ger075","article-title":"The role of ABC transporters in progression and clinical outcome of colorectal cancer","volume":"27","author":"Hlavata","year":"2012","journal-title":"Mutagenesis"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:23:40Z","timestamp":1620951820000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201702000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000257","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}